<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1395w–141" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1395w–141/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1395w–141/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1395w_141"><akn:num>1395w–141</akn:num><akn:heading>Medicare prescription drug discount card and transitional assistance program</akn:heading><akn:content><akn:p>§ 1395w–141. Medicare prescription drug discount card and transitional assistance program(a) Establishment of program(1) In generalThe Secretary shall establish a program under this section—(A) to endorse prescription drug discount card programs that meet the requirements of this section in order to provide access to prescription drug discounts through prescription drug card sponsors for discount card eligible individuals throughout the United States; and

(B) to provide for transitional assistance for transitional assistance eligible individuals enrolled in such endorsed programs.


(2) Period of operation(A) Implementation deadlineThe Secretary shall implement the program under this section so that discount cards and transitional assistance are first available by not later than 6 months after December 8, 2003.


(B) Expediting implementationThe Secretary shall promulgate regulations to carry out the program under this section which may be effective and final immediately on an interim basis as of the date of publication of the interim final regulation. If the Secretary provides for an interim final regulation, the Secretary shall provide for a period of public comments on such regulation after the date of publication. The Secretary may change or revise such regulation after completion of the period of public comment.


(C) Termination and transition(i) In generalSubject to clause (ii)—(I) the program under this section shall not apply to covered discount card drugs dispensed after December 31, 2005; and

(II) transitional assistance shall be available after such date to the extent the assistance relates to drugs dispensed on or before such date.


(ii) TransitionIn the case of an individual who is enrolled in an endorsed discount card program as of December 31, 2005, during the individual’s transition period (if any) under clause (iii), in accordance with transition rules specified by the Secretary—(I) such endorsed program may continue to apply to covered discount</akn:p></akn:content><akn:subsection eId="subsec_1395w_141_a"><akn:num>(a)</akn:num><akn:heading>Establishment of program</akn:heading><akn:content><akn:p>(a) Establishment of program</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_b"><akn:num>(b)</akn:num><akn:heading>Eligibility for discount card and for transitional assistance</akn:heading><akn:content><akn:p>(b) Eligibility for discount card and for transitional assistance For purposes of this section:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_c"><akn:num>(c)</akn:num><akn:heading>Enrollment and enrollment fees</akn:heading><akn:content><akn:p>(c) Enrollment and enrollment fees</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_d"><akn:num>(d)</akn:num><akn:heading>Provision of information on enrollment and program features</akn:heading><akn:content><akn:p>(d) Provision of information on enrollment and program features</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_e"><akn:num>(e)</akn:num><akn:heading>Discount card features</akn:heading><akn:content><akn:p>(e) Discount card features</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_f"><akn:num>(f)</akn:num><akn:heading>Eligibility procedures for endorsed programs and transitional assistance</akn:heading><akn:content><akn:p>(f) Eligibility procedures for endorsed programs and transitional assistance</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_g"><akn:num>(g)</akn:num><akn:heading>Transitional assistance</akn:heading><akn:content><akn:p>(g) Transitional assistance</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_h"><akn:num>(h)</akn:num><akn:heading>Qualification of prescription drug card sponsors and endorsement of discount card programs; beneficiary protections</akn:heading><akn:content><akn:p>(h) Qualification of prescription drug card sponsors and endorsement of discount card programs; beneficiary protections</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_i"><akn:num>(i)</akn:num><akn:heading>Disclosure and oversight</akn:heading><akn:content><akn:p>(i) Disclosure and oversight</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395w_141_j"><akn:num>(j)</akn:num><akn:heading>Treatment of territories</akn:heading><akn:content><akn:p>(j) Treatment of territories</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>